Actionable news
0
All posts from Actionable news
Actionable news in ORMP: Oramed Pharmaceuticals Inc.,

Oramed to Present at PIONEERS 2016, Presented by Joseph Gunnar

JERUSALEM, April 28, 2016 /PRNewswire via COMTEX/ -- JERUSALEM, April 28, 2016 /PRNewswire/ --

Oramed Pharmaceuticals Inc. ORMP, -4.00% (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the Company will participate in the upcoming PIONEERS 2016 conference, presented by Joseph Gunnar & Co. LLC, taking place on May 5, 2016 in New York. Nadav Kidron, CEO of Oramed, will present a corporate overview at the conference.

Presentation Details:

PIONEERS 2016, presented by Joseph Gunnar Date: Thursday, May 5, 2016 Time: 11:30am EDT Location: New York Palace Hotel, Hubbard 1, New York City

About Oramed Pharmaceuticals

Oramed Pharmaceuticals is a technology pioneer in the field of oral delivery solutions for drugs currently delivered via injection. Established in 2006, Oramed's Protein Oral Delivery (POD [[] [TM] []] ) technology is based on over 30 years of research by top scientists at Jerusalem's Hadassah Medical Center. Oramed is seeking to revolutionize the treatment of diabetes through its proprietary flagship product, an orally ingestible insulin capsule (ORMD-0801). The Company completed multiple Phase II clinical trials under an Investigational New Drug application with the U.S. Food and Drug Administration. In addition, Oramed is developing an oral GLP-1 analog capsule (a>


More